Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study

BACKGROUND: Surgery is a curative treatment for patients with locally advanced colon cancer, but recurrences are frequent for those with stage III disease. FOLFOX adjuvant chemotherapy has been shown to improve recurrence-free survival and overall survival by more than 20% and is nowadays considered...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hendlisz, Alain, Golfinopoulos, Vassilis, Deleporte, Amelie, Paesmans, Marianne, Mansy, Hazem El, Garcia, Camilo, Peeters, Marc, Annemans, Lieven, Vandeputte, Caroline, Maetens, Marion, Borbath, Ivan, Dresse, Damien, Houbiers, Ghislain, Fried, Michael, Awada, Ahmad, Piccart, Martine, Laethem, Jean-Luc Van, Flamen, Patrick
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637567/
https://ncbi.nlm.nih.gov/pubmed/23587148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-190
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars